All Press Releases for August 18, 2017

Dr. Roger Geoffrey Mazlen Named a Lifetime Achiever by Marquis Who's Who

Dr. Mazlen will be speaking at the annual Breast Cancer Conference in October 2017, as an expert on nutrition and medicine



    NEW YORK, NY, August 18, 2017 /24-7PressRelease/ -- Marquis Who's Who, the world's premier publisher of biographical profiles, is proud to name Dr. Roger Geoffrey Mazlen a Lifetime Achiever. An accomplished listee, Dr. Mazlen celebrates many years' experience in his professional network, and has been noted for achievements, leadership qualities, and the credentials and successes he has accrued in his field. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.

As head of Mazlen Medical Arts, PC, Dr. Mazlen applies over three decades of experience in internal medicine and pharmaceuticals to private practice and advanced medical research. His specialty is immunity, especially in the diagnosis and treatment of infection, immunological dysfunction, fibromyalgia, and managing cancer malnutrition or fatigue. In particular, Dr. Mazlen has treated over a thousand cases of chronic fatigue immune dysfunction (CFIDS). He also has clinical experience with Lyme disease, heavy metal toxicity, and sleep disorders. His practice, based out of Roslyn, New York, is motivated by a mission of giving an individualized approach to health care.

Dr. Mazlen earned a Bachelor of Science in biology from the prestigious Rensselaer Polytechnic Institute in 1959 and an M.D. from the State University of New York, Brooklyn, in 1963. He interned at the Maimonides Medical Center nearby before serving his residency there. In 1965, he became a research associate in the National Institutes of Health at Bethesda, Maryland, before serving a second residency in medical ophthalmology at Mount Sinai Medical Center. From 1965 to 1967, he also served with the U.S. Public Health Service. In 1968 he was awarded a U.S.P.H.S. two-year post doctoral fellowship to work at Harvard Medical School with the Peter Bent Bringham Hospital in Boston.

In 1970, Dr. Mazlen was an associate medical director at Pfizer, Inc, and in 1971, he directed clinical research at Ayerst Laboratories in New York while serving as senior faculty at the division of endocrinology and metabolism at Mount Sinai Medical Center. At Ayerst Laboratories, he developed and conducted clinical research studies leading to the approval of Inderal, the first beta-blocker to be used in medicine in the U.S. Dr. Mazlen was associate director for clinical research at Schering Corp. until 1978, at which time he devoted his time to Mount Sinai and his private practice.

Dr. Mazlen has served the health of his community as a consultant with the Professional Children's School in New York and as a consultant on nutrition and metabolism with South Oaks Hospital in Amityville, NY. He has also been an author, contributing to a chapter in "Quick Reference to Clinical Nutrition" and collaborating on "Nutrition and Health Care." He has spoken as a medical lecturer and was a former director of clinical research at the North American Immunotec Ltd. in Montreal, as well as a former chair of the hyperalimentation committee at Astoria General Hospital. Dr. Mazlen is a fellow and former chair of the American College of Nutrition, as well as a member of the American Chemistry Society, the Society for Natural Immunity, the American College of Cardiology, and was awarded the Good Doctors List award for his work in CFIDS. Notably, he was active for many years in the Society of Clinical Pharmacology and Therapeutics. He received New York Magazine's Top Doctor Award for Internal Medicine (2017), was named a Top Doctor USA and was recognized with the Albert Nelson Lifetime Achievement Award (2017). Dr. Mazlen is a reoccuring speaker at the annual Breast Cancer Conference, as an expert on nutrition and medicine for cancer treatment, sponsored by the Sass Medical Research Foundation.

In 1972 Dr. Mazlen wrote "A New Manifesto for Middle America," with a mind for civic duty. He has served on the board of the Bayside Hills Civic Association, in various capacities for the Sass Foundation, and is a founder and former chair of the Queens Country Common Cause organization. For his dedication to internal medicine and services to medical research, Dr. Mazlen was selected for inclusion in numerous volumes of Who's Who in America, Who's Who in Medicine and Healthcare, Who's Who in the East, Who's Who in the World and two volumes of Who's Who in Science and Engineering. He has two children. To contact Dr. Mazlen's private practice, please visit http://www.drmazlen.com.

In recognition of outstanding contributions to his profession and the Marquis Who's Who community, Dr. Mazlen has been featured on the Marquis Who's Who Lifetime Achievers website. Please visit www.ltachievers.com for more information about this honor.

About Marquis Who's Who :
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America , Marquis Who's Who has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Today, Who's Who in America remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. Marquis publications may be visited at the official Marquis Who's Who website at www.marquiswhoswho.com.

# # #

Contact Information

Fred Marks
Marquis Who's Who Ventures LLC
Berkeley Heights, NJ
USA
Voice: 844-394-6946
E-Mail: Email Us Here
Website: Visit Our Website
Follow Us: